DK3510042T3 - Fremgangsmåde til rensning af antistoffer - Google Patents
Fremgangsmåde til rensning af antistoffer Download PDFInfo
- Publication number
- DK3510042T3 DK3510042T3 DK17786994.8T DK17786994T DK3510042T3 DK 3510042 T3 DK3510042 T3 DK 3510042T3 DK 17786994 T DK17786994 T DK 17786994T DK 3510042 T3 DK3510042 T3 DK 3510042T3
- Authority
- DK
- Denmark
- Prior art keywords
- antibodies
- purification
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
- B01D15/424—Elution mode
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3804—Affinity chromatography
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662384240P | 2016-09-07 | 2016-09-07 | |
| PCT/IB2017/055374 WO2018047080A1 (en) | 2016-09-07 | 2017-09-06 | Methods for purifying antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3510042T3 true DK3510042T3 (da) | 2024-06-10 |
Family
ID=60138654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17786994.8T DK3510042T3 (da) | 2016-09-07 | 2017-09-06 | Fremgangsmåde til rensning af antistoffer |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11530238B2 (da) |
| EP (2) | EP3510042B1 (da) |
| JP (3) | JP7058272B2 (da) |
| KR (1) | KR102489451B1 (da) |
| CN (1) | CN109689675A (da) |
| AU (1) | AU2017323583A1 (da) |
| BR (1) | BR112019004459A2 (da) |
| CA (1) | CA3035853A1 (da) |
| DK (1) | DK3510042T3 (da) |
| ES (1) | ES2979153T3 (da) |
| IL (1) | IL265016B (da) |
| RU (1) | RU2759909C2 (da) |
| SG (1) | SG11201901059QA (da) |
| WO (1) | WO2018047080A1 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3510042B1 (en) * | 2016-09-07 | 2024-05-22 | GlaxoSmithKline Intellectual Property Development Limited | Methods for purifying antibodies |
| TW202003555A (zh) * | 2018-03-07 | 2020-01-16 | 英商葛蘭素史克智慧財產發展有限公司 | 用於純化重組多肽之方法 |
| TW202000891A (zh) * | 2018-03-07 | 2020-01-01 | 英商葛蘭素史克智慧財產發展有限公司 | 純化抗體之方法 |
| SG11202009503PA (en) * | 2018-05-04 | 2020-11-27 | Sigma Aldrich Co Llc | Engineered cells with modified host cell protein profiles |
| GB201904741D0 (en) * | 2019-04-04 | 2019-05-22 | Glaxosmithkline Ip Dev Ltd | Novel process |
| KR20220069043A (ko) * | 2019-09-23 | 2022-05-26 | 머크 샤프 앤드 돔 코포레이션 | 감소된 숙주 세포 단백질 및 증가된 폴리소르베이트-80 안정성을 갖는 항-ctla4 모노클로날 항체를 포함하는 방법 및 조성물 |
| WO2021222120A1 (en) * | 2020-04-27 | 2021-11-04 | Alexion Pharmaceuticals, Inc. | Protein a chromatography purification of an antibody |
| CN113281430A (zh) * | 2021-05-11 | 2021-08-20 | 苏州君盟生物医药科技有限公司 | 一种双特异性抗体的分离鉴定方法 |
| CN115161308A (zh) * | 2022-06-13 | 2022-10-11 | 江苏丰华生物制药有限公司 | 一种注射用替奈普酶上清液的纯化方法 |
| WO2024184183A1 (en) * | 2023-03-03 | 2024-09-12 | UCB Biopharma SRL | Method for host cell protein detection |
| EP4438614A1 (en) * | 2023-03-31 | 2024-10-02 | Sanofi | Methods for purifying heteromultimeric antibodies |
| WO2025133047A1 (en) | 2023-12-22 | 2025-06-26 | Novo Nordisk A/S | System and methods for counter-current filtration |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57106673A (en) | 1980-12-24 | 1982-07-02 | Chugai Pharmaceut Co Ltd | Dibenzo(b,f)(1,4)oxazepin derivative |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5429746A (en) | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
| US6955917B2 (en) | 1997-06-20 | 2005-10-18 | Bayer Healthcare Llc | Chromatographic method for high yield purification and viral inactivation of antibodies |
| IL127127A0 (en) | 1998-11-18 | 1999-09-22 | Peptor Ltd | Small functional units of antibody heavy chain variable regions |
| ATE290323T1 (de) | 2001-06-01 | 2005-03-15 | Upfront Chromatography As | Fraktionierung von proteinhaltigen mischungen |
| ES2337986T3 (es) | 2001-08-10 | 2010-05-03 | Aberdeen University | Dominios de union de antigenos de peces. |
| KR20050026396A (ko) | 2002-05-31 | 2005-03-15 | 인디언 카운실 오브 애그리컬쳐럴 리서치 | Ｂｔ-ｃｒｙ 독소의 고속 검출법 |
| PT1718675E (pt) | 2004-02-27 | 2013-05-21 | Octapharma Ag | Método de proporcionar uma preparação purificada de anticorpos livre de vírus |
| US20050272917A1 (en) | 2004-05-14 | 2005-12-08 | Hematech, Llc | Methods for immunoglobulin purification |
| CN103028380B (zh) * | 2006-01-06 | 2015-08-19 | Emd密理博公司 | 亲和层析基质及其制备和使用方法 |
| WO2007109163A2 (en) | 2006-03-16 | 2007-09-27 | Amgen Inc | Wash buffer and method of using |
| WO2007117490A2 (en) * | 2006-04-05 | 2007-10-18 | Abbott Biotechnology Ltd. | Antibody purification |
| WO2008031020A2 (en) * | 2006-09-08 | 2008-03-13 | Wyeth | Arginine wash in protein purification using affinity chromatography |
| WO2008085988A1 (en) | 2007-01-05 | 2008-07-17 | Amgen Inc. | Methods of purifying proteins |
| DK2848625T3 (da) * | 2008-08-14 | 2019-10-07 | Genentech Inc | Fremgangsmåder til fjernelse af en kontaminant under anvendelse af ion bytningsmembrankromatografi med forskydning af naturligt forekommende proteiner |
| US9624261B2 (en) | 2011-03-29 | 2017-04-18 | Glaxosmithkline Llc | Buffer system for protein purification |
| EP3680000B1 (en) | 2013-03-15 | 2024-03-13 | GlaxoSmithKline Intellectual Property Development Limited | Methods for purifying antibodies |
| WO2014186350A1 (en) | 2013-05-15 | 2014-11-20 | Medimmune Limited | Purification of recombinantly produced polypeptides |
| NZ756750A (en) * | 2013-09-13 | 2022-05-27 | Genentech Inc | Methods and compositions comprising purified recombinant polypeptides |
| ES2915378T3 (es) | 2013-09-13 | 2022-06-22 | Hoffmann La Roche | Procedimientos para detectar y cuantificar una proteína de célula huésped en líneas celulares |
| EP3510042B1 (en) * | 2016-09-07 | 2024-05-22 | GlaxoSmithKline Intellectual Property Development Limited | Methods for purifying antibodies |
-
2017
- 2017-09-06 EP EP17786994.8A patent/EP3510042B1/en active Active
- 2017-09-06 CA CA3035853A patent/CA3035853A1/en not_active Abandoned
- 2017-09-06 KR KR1020197009554A patent/KR102489451B1/ko active Active
- 2017-09-06 SG SG11201901059QA patent/SG11201901059QA/en unknown
- 2017-09-06 RU RU2019109975A patent/RU2759909C2/ru active
- 2017-09-06 AU AU2017323583A patent/AU2017323583A1/en not_active Abandoned
- 2017-09-06 EP EP24169899.2A patent/EP4389757A3/en active Pending
- 2017-09-06 DK DK17786994.8T patent/DK3510042T3/da active
- 2017-09-06 CN CN201780055118.6A patent/CN109689675A/zh active Pending
- 2017-09-06 ES ES17786994T patent/ES2979153T3/es active Active
- 2017-09-06 JP JP2019533715A patent/JP7058272B2/ja active Active
- 2017-09-06 BR BR112019004459A patent/BR112019004459A2/pt not_active Application Discontinuation
- 2017-09-06 US US16/330,588 patent/US11530238B2/en active Active
- 2017-09-06 WO PCT/IB2017/055374 patent/WO2018047080A1/en not_active Ceased
-
2019
- 2019-02-24 IL IL265016A patent/IL265016B/en unknown
-
2021
- 2021-12-27 JP JP2021213474A patent/JP2022058441A/ja active Pending
-
2022
- 2022-11-01 US US17/978,791 patent/US20230046182A1/en active Pending
-
2023
- 2023-12-04 JP JP2023204927A patent/JP2024037787A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019530744A (ja) | 2019-10-24 |
| RU2759909C2 (ru) | 2021-11-18 |
| RU2019109975A3 (da) | 2020-12-17 |
| EP3510042A1 (en) | 2019-07-17 |
| EP3510042B1 (en) | 2024-05-22 |
| EP4389757A3 (en) | 2025-01-01 |
| KR102489451B1 (ko) | 2023-01-16 |
| JP7058272B2 (ja) | 2022-04-21 |
| WO2018047080A1 (en) | 2018-03-15 |
| US11530238B2 (en) | 2022-12-20 |
| BR112019004459A2 (pt) | 2019-05-28 |
| ES2979153T3 (es) | 2024-09-24 |
| SG11201901059QA (en) | 2019-03-28 |
| JP2024037787A (ja) | 2024-03-19 |
| IL265016B (en) | 2021-10-31 |
| AU2017323583A1 (en) | 2019-03-14 |
| US20230046182A1 (en) | 2023-02-16 |
| US20210284686A1 (en) | 2021-09-16 |
| EP4389757A2 (en) | 2024-06-26 |
| KR20190043601A (ko) | 2019-04-26 |
| RU2019109975A (ru) | 2020-10-08 |
| CA3035853A1 (en) | 2018-03-15 |
| JP2022058441A (ja) | 2022-04-12 |
| CN109689675A (zh) | 2019-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3268390T3 (da) | Fremgangsmåder til oprensning af bispecifikke antistoffer | |
| IL263690A (en) | Purification of multispecific antibodies | |
| DK3510042T3 (da) | Fremgangsmåde til rensning af antistoffer | |
| DK3563156T3 (da) | Fremgangsmåde til separering af biomolekyler | |
| DK3292134T3 (da) | Metode til dyrkning af akkermansia | |
| DK3113858T3 (da) | Fremgangsmåde til oprensning af il-15/il-15ralpha-baserede konjugater | |
| DK3301115T3 (da) | Kontinuerlig flertrinsfremgangsmåde til oprensning af antistoffer | |
| DK3473621T3 (da) | Fremgangsmåde til fremstilling af diphenylmethan-derivat | |
| DK3556775T3 (da) | Anti-lag-3 antistoffer til behandling af hæmatologiske maligniteter | |
| DK3116891T3 (da) | Immunglobulinrensning ved hjælp af forrensningstrin | |
| DK3201361T3 (da) | Fremgangsmåder til kvantificering af cellefrit DNA | |
| DK3285784T3 (da) | Fremgangsmåde til fremstilling af en prøve af fækal mikrobiota | |
| DK3287523T3 (da) | Fremgangsmåde til sekretorisk fremstilling af protein | |
| DK3122444T3 (da) | Fremgangsmåde til fremstilling af membraner | |
| DK3458100T3 (da) | Selektiv reduktion af cystein-manipulerede antistoffer | |
| DK3515990T3 (da) | Fremgangsmåde til fremstilling af lignocellulosematerialer | |
| DK3680000T3 (da) | Fremgangsmåder til oprensning af antistoffer | |
| DK3665173T3 (da) | Ny fremgangsmåde til yntetisering af amanitiner | |
| DK3487443T3 (da) | Fremgangsmåde til opmåling af en implantat-implantat-situation | |
| DK3334747T3 (da) | Ladet dybdefiltrering af antigenbindende proteiner | |
| DK3218396T3 (da) | Fremgangsmåde til fremstilling af højaffinitets antistoffer | |
| DK3347481T3 (da) | Fremgangsmåde til oprensning af biomassehydrolysat | |
| DK3147369T3 (da) | Fremgangsmåde til produktion af fibroinlignende protein | |
| DK3661562T3 (da) | Fremgangsmåde til konjugation af cys-mabs | |
| DK3535257T3 (da) | Fremgangsmåde til oprensning af pyrazolpyridaziner |